Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares stood at 0.3 million during the latest session, with the company’s beta value hitting 5.14. At the last check today, the stock’s price was $0.25, to imply an increase of 0.04% or $0.0 in intraday trading. The APVO share’s 52-week high remains $15.14, putting it -5956.0% down since that peak but still an impressive 44.0% since price per share fell to its 52-week low of $0.14. The company has a valuation of $2.33M, with an average of 31.16 million shares in intraday trading volume over the past 10 days and average of 5.75 million shares over the past 3 months.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
After registering a 0.04% upside in the latest session, Aptevo Therapeutics Inc (APVO) has traded red over the past five days. The 5-day price performance for the stock is 24.43%, and 37.22% over 30 days. With these gigs, the year-to-date price performance is -96.90%. Short interest in Aptevo Therapeutics Inc (NASDAQ:APVO) saw shorts transact 58354.0 shares and set a 0.02 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptevo Therapeutics Inc (APVO) estimates and forecasts
Looking at statistics comparing Aptevo Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Aptevo Therapeutics Inc (APVO) shares are -65.02% down over the last 6 months, with its year-to-date growth rate higher than industry average at 95.56% against 17.50%. Revenue is forecast to grow 84.80% this quarter before jumping 48.50% for the next one.
APVO Dividends
Aptevo Therapeutics Inc has its next earnings report out on 2024-Nov-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Aptevo Therapeutics Inc insiders hold 0.04% of total outstanding shares, with institutional holders owning 14.61% of the shares at 14.62% float percentage. In total, 14.61% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Aptevo Therapeutics Inc (APVO) shares. Going by data provided on Aug 31, 2024, Fidelity Extended Market Index Fund holds roughly 19.05 shares. This is just over 0.20% of the total shares, with a market valuation of $4571.0. Data from the same date shows that the other fund manager holds a little less at 2.08, or 0.02% of the shares, all valued at about 500.0.
